These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 29384030

  • 21. Can increases in CHIP copayments reduce program expenditures on prescription drugs?
    Sen B, Blackburn J, Morrisey M, Becker D, Kilgore M, Caldwell C, Menachemi N.
    Medicare Medicaid Res Rev; 2014; 4(2):. PubMed ID: 24967148
    [Abstract] [Full Text] [Related]

  • 22. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K, Farley JF, Maciejewski ML, Domino ME.
    J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
    Dusetzina SB, Sarpatwari A, Carrier MA, Hansen RA, Keating NL, Huskamp HA.
    JAMA Intern Med; 2021 Dec 01; 181(12):1605-1611. PubMed ID: 34661600
    [Abstract] [Full Text] [Related]

  • 29. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA, Polinski JM, Choudhry NK, Avorn J, Fischer MA.
    BMC Health Serv Res; 2016 Jan 15; 16():15. PubMed ID: 26772962
    [Abstract] [Full Text] [Related]

  • 30. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M, Lawson KA, Shepherd MD.
    J Manag Care Pharm; 2007 Mar 15; 13(2):122-34. PubMed ID: 17330973
    [Abstract] [Full Text] [Related]

  • 31. Implementation of an opioid management initiative by a state Medicaid program.
    Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P.
    J Manag Care Spec Pharm; 2014 May 15; 20(5):447-54. PubMed ID: 24761816
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of a 3-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals With Chronic Disease.
    Nair KV, Wolfe P, Valuck RJ, McCollum MM, Ganther JM, Lewis SJ.
    J Manag Care Spec Pharm; 2020 May 15; 26(5):575-585. PubMed ID: 32347176
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Do drug formulary policies reflect evidence of value?
    Neumann PJ, Lin PJ, Greenberg D, Berger M, Teutsch S, Mansley E, Weinstein MC, Rosen AB.
    Am J Manag Care; 2006 Jan 15; 12(1):30-6. PubMed ID: 16402886
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.